# Prospective Study for the Application of Cytosorb® in Critically Ill Patients

> **NCT04913298** · NA · COMPLETED · sponsor: **Ludwig-Maximilians - University of Munich** · enrollment: 57 (actual)

## Conditions studied

- Rhabdomyolysis
- Acute Liver Injury
- Cytokine Storm

## Interventions

- **DEVICE:** Cytosorb therapy

## Key facts

- **NCT ID:** NCT04913298
- **Lead sponsor:** Ludwig-Maximilians - University of Munich
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-01
- **Primary completion:** 2023-04-30
- **Final completion:** 2023-12-15
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2024-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04913298

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04913298, "Prospective Study for the Application of Cytosorb® in Critically Ill Patients". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04913298. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*